Participate in Surveys and WIN POINTS!

Survey on use of Valproic acid

Dear Doctor - Participate in the Survey on valproic acid "A new survey has found that the use of Valproic acid is on the rise among people with epilepsy. The survey, which was conducted by the Epilepsy Foundation, found that nearly a third of respondents said they had used Valproic acid in the past year to treat their seizures. This is up from just over a fifth in a previous survey. Valproic acid is an anticonvulsant medication that is commonly used to treat epilepsy. It can be taken as a pill or liquid, and it works by reducing seizure activity in the brain. The medication is generally considered to be safe and effective, but there are some potential side effects, including drowsiness, nausea, vomiting, and weight gain.If you have epilepsy and are considering using Valproic acid to treat your seizures, talk to your doctor to see if it is the right option for you. Participate now."


To take this Survey and to participate in more such Surveys

Recommended Surveys

Survey on hair fall


Urinary tract infections Survey


Survey on the overuse of paracetamol tablets


Epilepsy survey


Diabetes survey


Survey on hepatitis of unknown etiology in children


Survey on treating Hereditary angioedema


Survey on Use of AI in Health and Medicine


Survey on the use of neuroleptics


Flu Survey questions


Survey on use of Cefoperazone


Survey on NAFLD


CI-AKI awareness survey


Survey on Pink eye


Metoprolol Survey


HPV vaccine survey


Survey on serious skin infections


Survey on Growth hormone deficiency


Survey on prescribing nutritional supplements to children


Survey on dandruff



Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Colon cancer and exercise: Can physical activity reprogram genes?

2.

For relapsed or resistant DLBCL, odronextamab produced positive results.

3.

Improved end-of-life conversations for cancer patients are identified by a new study.

4.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

5.

Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.

Whats more on Hidoc Dr.

News
Quizzes
Surveys
Events

Daily news to keep you up to date

Participate and win exciting prizes

Participate and win cash vouchers

Get updates on the latest events happening around the world



© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot